For treatment of which conditions has the FDA approved intravenous immunoglobulin (IVIG)?

Updated: Jul 05, 2018
  • Author: Jessica Katz, MD, PhD, FACP; Chief Editor: Emmanuel C Besa, MD  more...
  • Print


The US Food and Drug Administration has approved the use of IVIG for the following conditions [13, 14, 15, 121] :

  • Chronic lymphocytic leukemia

  • Common variable immunodeficiency (CVID) - A group of approximately 150 primary immunodeficiencies (PIDs) that have a common set of features (including hypogammaglobulinemia) but that have different underlying causes

  • Chronic inflammatory demyelinating polyneuropathy (CIDP) - Solely Gamunex

  • Primary immunodeficiency disorders associated with defects in humoral immunity.

  • Immune-mediated thrombocytopenia

  • Kawasaki disease (see the Kawasaki Disease Diagnostic Criteria calculator)

  • Multifocal motor neuropathy

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!